Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Merck dives into COPD treatments with $10 billion purchase of Verona Pharma
07:48am, Wednesday, 09'th Jul 2025
Verona Pharma's stock soars toward a record after $10 billion buyout deal with Merck.
Merck buys Verona for $10 billion
07:47am, Wednesday, 09'th Jul 2025
Evan Seigerman, BMO senior biopharma analyst, joins 'Squawk Box' to discuss Merck's decision to buy Verona, the potential impact of sector tariffs and much more.
Verona Pharma Stock Jumps 21%. It's Being Bought for $10 Billion by Merck.
07:14am, Wednesday, 09'th Jul 2025
The deal is expected to close in the fourth quarter of 2025.
Merck to Buy Verona Pharma in $10 Billion Deal
06:48am, Wednesday, 09'th Jul 2025
Merck has struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup as it braces for the 2028 loss of patent exclusivity for the blockbuster cancer drug Keytruda.
Merck to acquire Verona Pharma for $10 billion
06:39am, Wednesday, 09'th Jul 2025
Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's presence in respiratory treatments as it readies for the patent expiry of it
RAHWAY, N.J. & RALEIGH, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical
Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports
01:09am, Wednesday, 09'th Jul 2025
Merck is nearing a roughly $10 billion deal to buy lung disease-focused biotech Verona Pharma, the Financial Times reported on Wednesday.
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025
06:45am, Tuesday, 08'th Jul 2025
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that new data from its research pipeline for HIV prevention and tr
My Top 10 High-Yield Dividend Stocks For July 2025: One Yields 12%-Plus
06:00pm, Monday, 07'th Jul 2025
I present my top 10 high-yield dividend stocks for July 2025, screened for strong yields, large market caps, and attractive valuations. The list includes Chevron, Pfizer, PepsiCo, Ares Capital, BB Seg
Merck & Co.: A Pharma Titan At A Discount
12:48pm, Monday, 07'th Jul 2025
Merck & Co. (MRK) is currently down ≈18% YTD, a result of the 2028 patent cliff, weak demand for Gardasil in China, and IRA price controls. Despite these headwinds, my DCF Model shows that at its cu
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
07:30am, Monday, 07'th Jul 2025
I've written this kind of article before, addressing whether it's smart to buy into the dividend-paying stocks in the S&P 500 or Nasdaq Composite that have the highest dividend yields. There are some
Merck Mercuriadis plots return with new Hipgnosis venture after market rebound
03:01am, Monday, 07'th Jul 2025
Merck Mercuriadis is launching a fresh version of Hipgnosis Songs Fund Limited (LSE:SONG), the music rights venture he founded in 2018, as investors return to the sector following a bruising correctio
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)
08:00am, Saturday, 05'th Jul 2025
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Thursday, 03'rd Jul 2025
In the latest trading session, Merck (MRK) closed at $80.93, marking a -1.77% move from the previous day.
MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE
09:31am, Thursday, 03'rd Jul 2025
Merck eyes growth beyond Keytruda with PAH drug Winrevair, aiming to offset the looming loss of exclusivity in 2028.
